{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T07:56:01Z","timestamp":1714377361405},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T00:00:00Z","timestamp":1461024000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T00:00:00Z","timestamp":1461024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1245\/s10434-016-5231-2","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T18:23:31Z","timestamp":1461090211000},"page":"2946-2952","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Impact of Major Complications on Patients\u2019 Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy"],"prefix":"10.1245","volume":"23","author":[{"given":"Trevor D.","family":"Hamilton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily L.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda J.","family":"Cannell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Andrea","family":"McCart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Govindarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,19]]},"reference":[{"issue":"5","key":"5231_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/bjs.8679","volume":"99","author":"J Segelman","year":"2012","unstructured":"Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2012;99(5):699\u2013705. doi:\n                    10.1002\/bjs.8679\n                    \n                  .","journal-title":"Br J Surg."},{"issue":"12","key":"5231_CR2","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","volume":"89","author":"DG Jayne","year":"2002","unstructured":"Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002;89(12):1545\u201350. doi:\n                    10.1046\/j.1365-2168.2002.02274.x\n                    \n                  .","journal-title":"Br J Surg."},{"issue":"9","key":"5231_CR3","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","volume":"15","author":"VJ Verwaal","year":"2008","unstructured":"Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15(9):2426\u201332. doi:\n                    10.1245\/s10434-008-9966-2\n                    \n                  .","journal-title":"Ann Surg Oncol."},{"issue":"20","key":"5231_CR4","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30(20):2449\u201356. doi:\n                    10.1200\/JCO.2011.39.7166\n                    \n                  .","journal-title":"J Clin Oncol."},{"issue":"24","key":"5231_CR5","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1002\/cncr.25356","volume":"116","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Boutitie F, et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Cancer. 2010;116(24):5608\u201318. doi:\n                    10.1002\/cncr.25356\n                    \n                  .","journal-title":"Cancer."},{"issue":"4","key":"5231_CR6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jamcollsurg.2013.12.013","volume":"218","author":"EA Levine","year":"2014","unstructured":"Levine EA, Stewart JH IV, Shen P, Russell GB, Loggie BL, Votanopoulos KI. Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg. 2014;218(4):573\u201385. doi:\n                    10.1016\/j.jamcollsurg.2013.12.013\n                    \n                  .","journal-title":"J Am Coll Surg."},{"issue":"1","key":"5231_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1053\/ejso.2000.1033","volume":"27","author":"RP McQuellon","year":"2001","unstructured":"McQuellon RP, Loggie BW, Fleming RA, Russell GB, Lehman AB, Rambo TD. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol. 2001;27(1):65\u201373. doi:\n                    10.1053\/ejso.2000.1033\n                    \n                  .","journal-title":"Eur J Surg Oncol."},{"issue":"12","key":"5231_CR8","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1245\/s10434-006-9186-6","volume":"13","author":"TM Tuttle","year":"2006","unstructured":"Tuttle TM, Zhang Y, Greeno E, Knutsen A. Toxicity and quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2006;13(12):1627\u201332. doi:\n                    10.1245\/s10434-006-9186-6\n                    \n                  .","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"5231_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1245\/s10434-007-9678-z","volume":"15","author":"RP McQuellon","year":"2007","unstructured":"McQuellon RP, Russell GB, Shen P, Stewart JH IV, Saunders W, Levine EA. Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin. Ann Surg Oncol. 2007;15(1):125\u201333. doi:\n                    10.1245\/s10434-007-9678-z\n                    \n                  .","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"5231_CR10","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.ejso.2013.12.028","volume":"40","author":"CS Chia","year":"2014","unstructured":"Chia CS, Tan WJ, Wong JFS, et al. Quality of life in patients with peritoneal surface malignancies after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol. 2014;40(8):909\u201316. doi:\n                    10.1016\/j.ejso.2013.12.028\n                    \n                  .","journal-title":"Eur J Surg Oncol."},{"issue":"4","key":"5231_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/jso.21050","volume":"98","author":"R McQuellon","year":"2008","unstructured":"McQuellon R, Gavazzi C, Piso P, Swain D, Levine E. Quality of life and nutritional assessment in peritoneal surface malignancy (PSM): recommendations for care. J Surg Oncol. 2008;98(4):300\u20135. doi:\n                    10.1002\/jso.21050\n                    \n                  .","journal-title":"J Surg Oncol."},{"issue":"2","key":"5231_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1245\/ASO.2003.03.067","volume":"10","author":"RP McQuellon","year":"2003","unstructured":"McQuellon RP, Loggie BW, Lehman AB, et al. Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol. 2003;10(2):155\u201362. doi:\n                    10.1245\/ASO.2003.03.067\n                    \n                  .","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"5231_CR13","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/jso.23089","volume":"106","author":"KE Duckworth","year":"2012","unstructured":"Duckworth KE, McQuellon RP, Russell GB, et al. Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS\u2009\u00a0+\u00a0\u2009HIPEC). J Surg Oncol. 2012;106(4):376\u201380. doi:\n                    10.1002\/jso.23089\n                    \n                  .","journal-title":"J Surg Oncol."},{"issue":"2","key":"5231_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jamasurg.2013.3640","volume":"149","author":"MD Jafari","year":"2014","unstructured":"Jafari MD, Halabi WJ, Stamos MJ, et al. Surgical outcomes of hyperthermic intraperitoneal chemotherapy. JAMA Surg. 2014;149(2):170\u20136. doi:\n                    10.1001\/jamasurg.2013.3640\n                    \n                  .","journal-title":"JAMA Surg."},{"issue":"2","key":"5231_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/00000658-199502000-00002","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg. 1995;221(2):124\u201332.","journal-title":"Ann Surg."},{"issue":"5","key":"5231_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrumentfor use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365\u201376.","journal-title":"J Natl Cancer Inst."},{"key":"5231_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/BF00449426","volume":"2","author":"HE Niezgoda","year":"1993","unstructured":"Niezgoda HE, Pater JL. A validation study of the domains of the core EORTC quality of life questionnaire. Qual Life Res. 1993;2:319\u201325.","journal-title":"Qual Life Res."},{"issue":"4","key":"5231_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0895-4356(96)00428-3","volume":"50","author":"M Groenvold","year":"1997","unstructured":"Groenvold M, Klee MC, Sprangers MAG, Aaronson NK. Validation of the EORTC QLQC30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol. 1997;50(4):441\u201350.","journal-title":"J Clin Epidemiol."},{"issue":"4","key":"5231_CR19","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/S0959-8049(97)10076-4","volume":"34","author":"S-A McLachlan","year":"1998","unstructured":"McLachlan S-A, Devins GM, Goodwin PJ. Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients. Eur J Cancer. 1998;34(4):510\u20137.","journal-title":"Eur J Cancer."},{"issue":"1","key":"5231_CR20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","volume":"16","author":"D Osoba","year":"1998","unstructured":"Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16(1):139\u201344.","journal-title":"J Clin Oncol."},{"issue":"2","key":"5231_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg. 2004;240(2):205\u201313. doi:\n                    10.1097\/01.sla.0000133083.54934.ae\n                    \n                  .","journal-title":"Ann Surg."},{"issue":"6","key":"5231_CR22","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1007\/s10350-008-9223-6","volume":"51","author":"P Jess","year":"2008","unstructured":"Jess P, Iversen LH, Nielsen MB, Hansen F, Laurberg S, Rasmussen PC. Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective study. Dis Colon Rectum. 2008;51(6):868\u201374. doi:\n                    10.1007\/s10350-008-9223-6\n                    \n                  .","journal-title":"Dis Colon Rectum."},{"issue":"12","key":"5231_CR23","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.ejso.2010.09.004","volume":"36","author":"S Alves","year":"2010","unstructured":"Alves S, Mohamed F, Yadegarfar G, Youssef H, Moran BJ. Prospective longitudinal study of quality of life following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Eur J Surg Oncol. 2010;36(12):1156\u201361. doi:\n                    10.1016\/j.ejso.2010.09.004\n                    \n                  .","journal-title":"Eur J Surg Oncol."},{"issue":"1","key":"5231_CR24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1245\/s10434-012-2579-9","volume":"20","author":"N Tsilimparis","year":"2012","unstructured":"Tsilimparis N, Bockelmann C, Raue W, et al. Quality of life in patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is it worth the risk? Ann Surg Oncol. 2012;20(1):226\u201332. doi:\n                    10.1245\/s10434-012-2579-9\n                    \n                  .","journal-title":"Ann Surg Oncol."},{"issue":"13","key":"5231_CR25","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1245\/s10434-011-1793-1","volume":"18","author":"AR Hill","year":"2011","unstructured":"Hill AR, McQuellon RP, Russell GB, Shen P, Stewart JH, Levine EA. Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin. Ann Surg Oncol. 2011;18(13):3673\u20139. doi:\n                    10.1245\/s10434-011-1793-1\n                    \n                  .","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"5231_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000209277","volume":"76","author":"H Ishigami","year":"2009","unstructured":"Ishigami H, Kitayama J, Otani K, et al. Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer. Oncology. 2009;76(5):311\u20134. doi:\n                    10.1159\/000209277\n                    \n                  .","journal-title":"Oncology."},{"issue":"4","key":"5231_CR27","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1158\/1078-0432.CCR-06-1735","volume":"13","author":"RJ Morgan","year":"2007","unstructured":"Morgan RJ, Synold TW, Xi B, et al. Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity. Clin Cancer Res. 2007;13(4):1232\u20137. doi:\n                    10.1158\/1078-0432.CCR-06-1735\n                    \n                  .","journal-title":"Clin Cancer Res."},{"issue":"9384","key":"5231_CR28","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/S0140-6736(03)14186-4","volume":"362","author":"K Ahlberg","year":"2003","unstructured":"Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults. Lancet. 2003;362(9384):640\u201350. doi:\n                    10.1016\/S0140-6736(03)14186-4\n                    \n                  .","journal-title":"Lancet."},{"issue":"12","key":"5231_CR29","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.ejca.2006.01.059","volume":"42","author":"V Arndt","year":"2006","unstructured":"Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H. Restrictions in quality of life in colorectal cancer patients over three years after diagnosis: a population-based study. Eur J Cancer. 2006;42(12):1848\u201357. doi:\n                    10.1016\/j.ejca.2006.01.059\n                    \n                  .","journal-title":"Eur J Cancer."},{"issue":"8","key":"5231_CR30","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ejso.2004.06.015","volume":"30","author":"CP Carmignani","year":"2004","unstructured":"Carmignani CP, Sugarbaker PH. Synchronous extraperitoneal and intraperitoneal dissemination of appendix cancer. Eur J Surg Oncol. 2004;30(8):864\u20138. doi:\n                    10.1016\/j.ejso.2004.06.015\n                    \n                  .","journal-title":"Eur J Surg Oncol."},{"issue":"7","key":"5231_CR31","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.ejso.2015.02.016","volume":"41","author":"V Milovanov","year":"2015","unstructured":"Milovanov V, Sardi A, Aydin N, et al. Extensive surgical history prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with poor survival outcomes in patients with peritoneal mucinous carcinomatosis of appendiceal origin. Eur J Surg Oncol. 2015;41(7):881\u20135. doi:\n                    10.1016\/j.ejso.2015.02.016\n                    \n                  .","journal-title":"Eur J Surg Oncol."},{"issue":"2","key":"5231_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ejso.2008.04.002","volume":"35","author":"J Hansson","year":"2009","unstructured":"Hansson J, Graf W, P\u00e5hlman L, Nygren P, Mahteme H. Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol. 2009;35(2):202\u20138. doi:\n                    10.1016\/j.ejso.2008.04.002\n                    \n                  .","journal-title":"Eur J Surg Oncol."},{"issue":"1","key":"5231_CR33","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1016\/j.jss.2012.01.015","volume":"179","author":"K Votanopoulos","year":"2013","unstructured":"Votanopoulos K, Ihemelandu C, Shen P, Stewart J, Russell G, Levine EA. A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C. J Surg Res. 2013;179(1):e133\u20139. doi:\n                    10.1016\/j.jss.2012.01.015\n                    \n                  .","journal-title":"J Surg Res."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5231-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-016-5231-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5231-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5231-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T13:44:39Z","timestamp":1589809479000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-016-5231-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,19]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["5231"],"URL":"https:\/\/doi.org\/10.1245\/s10434-016-5231-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,19]]},"assertion":[{"value":"11 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2016","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}